Masimo Co. (NASDAQ:MASI) Shares Bought by NS Partners Ltd

NS Partners Ltd lifted its stake in shares of Masimo Co. (NASDAQ:MASI) by 2.3% during the 3rd quarter, Holdings Channel reports. The fund owned 43,037 shares of the medical equipment provider’s stock after buying an additional 986 shares during the quarter. NS Partners Ltd’s holdings in Masimo were worth $5,738,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. NBC Securities Inc. grew its position in Masimo by 47.1% in the 3rd quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 73 shares in the last quarter. Fifth Third Bancorp boosted its stake in shares of Masimo by 16.4% in the second quarter. Fifth Third Bancorp now owns 695 shares of the medical equipment provider’s stock valued at $88,000 after purchasing an additional 98 shares during the period. Oak Thistle LLC grew its holdings in shares of Masimo by 5.2% in the second quarter. Oak Thistle LLC now owns 2,079 shares of the medical equipment provider’s stock valued at $262,000 after purchasing an additional 103 shares in the last quarter. GAMMA Investing LLC grew its holdings in shares of Masimo by 75.0% in the second quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider’s stock valued at $33,000 after purchasing an additional 111 shares in the last quarter. Finally, HHM Wealth Advisors LLC increased its stake in Masimo by 25.0% during the 2nd quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider’s stock worth $79,000 after buying an additional 125 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Stock Up 1.7 %

Masimo stock opened at $163.50 on Wednesday. The stock has a market cap of $8.75 billion, a PE ratio of 112.76 and a beta of 0.97. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The stock’s fifty day moving average is $139.17 and its two-hundred day moving average is $127.02. Masimo Co. has a 1-year low of $91.60 and a 1-year high of $173.90.

Masimo (NASDAQ:MASI) last announced its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.14. The firm had revenue of $504.60 million during the quarter, compared to the consensus estimate of $502.87 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The firm’s quarterly revenue was up 5.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.63 earnings per share. On average, sell-side analysts expect that Masimo Co. will post 4.04 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have commented on MASI. Wells Fargo & Company raised their price target on shares of Masimo from $160.00 to $171.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a report on Wednesday, November 6th. BTIG Research boosted their target price on Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Piper Sandler increased their price target on Masimo from $165.00 to $180.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. Finally, Raymond James upgraded Masimo from a “market perform” rating to an “outperform” rating and set a $170.00 price objective for the company in a research note on Wednesday, November 6th. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Masimo presently has an average rating of “Moderate Buy” and an average target price of $163.67.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.